• Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor investor investor investor

€0.0

round
investor investor

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor investor

€0.0

round

€8.8m

Angel
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2020202120222023202420252026
Revenues0000000000000000000000000000
% growth-15 %-81 %4 %8 %58 %
EBITDA0000000000000000000000000000
% EBITDA margin-(181 %)(394 %)(278 %)(211 %)--
Profit0000000000000000000000000000
% profit margin-(422 %)(696 %)(432 %)(401 %)--
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue-15 %53 %14 %5 %--

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Nightingale Health

Edit
Yolife
ACQUISITION by Nightingale Health Jul 2021
Negen
ACQUISITION by Nightingale Health Jan 2022
Welltus
ACQUISITION by Nightingale Health Mar 2024